Search Results - "Jonuleit, T"
-
1
Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro
Published in European journal of medical research (30-07-2004)“…The aim of the present in vitro study has been to investigate the effects of a enriched platelet derived growth factors on proliferation and migration of human…”
Get more information
Journal Article -
2
Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines
Published in Blood (01-09-2000)“…Chronic myeloid leukemia (CML) is a malignant stem cell disease characterized by an expansion of myeloid progenitor cells expressing the constitutively…”
Get full text
Journal Article -
3
Preservation of G-CSF mobilized whole blood in an automated closed hollow-fiber bioreactor system
Published in Cytotherapy (Oxford, England) (01-08-2004)Get full text
Journal Article -
4
Monitoring of cell viability and cell growth in a hollow-fiber bioreactor by use of the dye Alamar Blue
Published in Journal of immunological methods (01-06-2001)“…We describe a method for monitoring cell proliferation in a small-scale hollow-fiber bioreactor (culture volume: 1 ml) by use of the Alamar Blue™ dye. Alamar…”
Get full text
Journal Article -
5
Observations on the microvasculature of bone defects filled with biodegradable nanoparticulate hydroxyapatite
Published in Biomaterials (01-08-2008)“…Abstract The microvascularization of metaphyseal bone defects filled with nanoparticulate, biodegradable hydroxyapatite biomaterial with and without platelet…”
Get full text
Journal Article -
6
Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines
Published in Blood (01-09-2000)“…Chronic myeloid leukemia (CML) is a malignant stem cell disease characterized by an expansion of myeloid progenitor cells expressing the constitutively…”
Get full text
Journal Article -
7
The Tyrosine Kinase Inhibitor CGP 57148 (ST1 571) Induces Apoptosis in BCR-ABL-positive Cells by Down-Regulating BCL-X
Published in Clinical cancer research (01-05-2000)“…CGP 57148 is a potent inhibitor of the ABL protein tyrosine kinase and a promising new compound for the treatment of a variety of BCR-ABL-positive leukemias…”
Get full text
Journal Article -
8
New blood vessel formation and expression of VEGF receptors after implantation of platelet growth factor-enriched biodegradable nanocrystalline hydroxyapatite
Published in Growth factors (Chur, Switzerland) (01-06-2005)“…Vascular endothelial growth factor (VEGF) plays a key role for the interaction of osteoblasts and endothelial cells and, therefore, is an important factor for…”
Get full text
Journal Article -
9
Bcr‐Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors
Published in British journal of haematology (01-02-1998)“…Cell cycle control of both immature and differentiated primary myeloid normal and chronic‐phase chronic myeloid leukaemia (CML) cells to growth factor…”
Get full text
Journal Article